Key result
Female sex is linked to similar 1-year major cardiovascular event rates compared to male sex.
Why the study?
Men and women differ in coronary artery disease presentation and management, but whether these differences translate into different clinical outcomes in stable CAD is unclear.
Does female sex affect the composite of cardiovascular death, non-fatal myocardial infarction, or stroke in outpatients with stable coronary artery disease?
Observational (n=30,977)
Yes
Does female sex affect the composite of cardiovascular death, non-fatal myocardial infarction, or stroke in outpatients with stable coronary artery disease?
Despite differences in baseline characteristics and management, women and men with stable coronary artery disease have similar 1-year cardiovascular outcomes.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“For the first time, we can see that many patients with CAD have too high resting heart rate levels, and combined internal evidence from CLARIFY and external evidence from prior sources indicate that this is associated with worse symptoms and worse clinical outcomes. These findings suggest tighter control of baseline heart rate with heart-rate-lowering medications may benefit CAD patients by improving symptom control and outcomes.”
Supports equivalent prognosis by sex in stable CAD outpatients; leaves open whether revascularization gaps reflect bias or appropriate care.
AIMS: Men and women differ in terms of presentation and management in coronary artery disease (CAD). Whether these differences translate into different clinical outcomes in stable CAD is unclear. We analysed data from the international prospective CLARIFY registry to compare cardiovascular clinical outcomes in men and women with stable CAD. METHODS AND RESULTS: We analysed 1-year outcomes in 30 977 outpatients with stable CAD [23 975 (77.4%) men; 7002 (22.6%) women]. Women were older than men, more likely to have hypertension and diabetes, and less likely to exercise or smoke. They had more frequent angina, but were less likely to have undergone diagnostic non-invasive testing or coronary angiography. Women received less optimized treatment for stable CAD. One-year outcomes were similar for men and women for the composite of cardiovascular death, non-fatal myocardial infarction, or stroke [adjusted rates 1.7 vs. 1.8%, respectively, odds ratio (OR) 0.93, 95% confidence interval (CI) 0.75-1.15]; all-cause death (adjusted 1.5 vs. 1.6%, OR: 0.91, 95% CI: 0.72-1.13); fatal or non-fatal myocardial infarction (adjusted 1.0 vs. 0.9%, OR: 0.81, 95 CI: 0.60-1.08); and cardiovascular death or non-fatal myocardial infarction (adjusted 1.4 vs. 1.4%, OR: 0.89, 95% CI: 0.70-1.12). Fewer women underwent revascularization (2.6 vs. 2.2%, OR: 0.77, 95% CI: 0.64-0.93), although appropriateness was not analysed. CONCLUSION: The risk profiles of women and men with stable CAD differ substantially. However, 1-year outcomes were similar. Fewer women underwent revascularization. Further research is needed to better understand gender determinants of outcome and devise strategies to minimize bias in the management and treatment of women.
No takes yet. Share an insight, caveat, or question.
Steg et al. (2012) conducted an observational in Stable coronary artery disease (n=30,977). Female sex vs. Male sex was evaluated on Composite of cardiovascular death, non-fatal myocardial infarction, or stroke (OR 0.93, 95% CI 0.75-1.15, p=0.50). In outpatients with stable coronary artery disease, female sex was associated with similar 1-year rates of cardiovascular death, non-fatal myocardial infarction, or stroke compared to male sex.
Synapse has enriched 10 related papers. Consider them for comparative context: